Related news:
GSK launches PS2bn buyback on strong HIV and cancer drugs sales - GSK's PS2 Billion Booster - GSK signs PS50m deal with Oxford University on cancer vaccines - GSK and Oxford researchers to create cancer vaccine to stop disease developing - GSK Nears $1 Billion Deal for Biotech Company IDRx - GSK nears $1bn deal for biotech developing drug for rare tumour - GSK, China's Zhifei Expand Shingles Shot Collaboration - GSK hails progress for withdrawn blood cancer drug - GSK lowers vaccine sales forecast as weak demand for RSV jab Arexvy takes toll - UK firm GSK to pay $2.2bn over Zantac cancer claims
GSK
Bookmark
ShareKey facts
- country: United Kingdom
- sector: Health Care
- industry: Pharmaceuticals
Classified as: organization
Summary
GSK is a company. It is located in the United Kingdom. The company is part of the Health Care sector, specifically in the Pharmaceuticals industry.
Business
GSK is one of the companies in the United Kingdom, companies in Pharmaceuticals, companies in Health Care and 3,466,499 companies in our database.
Stocks from GSK
Explore more on business
Talking Points:
- GSK Careers Apply
- GSK Careers Apply
- We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https:
- t.co
- NdSNH7YhFc
- A science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. | A science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. We have three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and ...
Learn more about talking points
